Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Emily Drabant Conley
|
| gptkbp:focusesOn |
microbiome therapeutics
|
| gptkbp:foundedIn |
2019
|
| gptkbp:fundedBy |
$50 million Series A
|
| gptkbp:headquartersLocation |
gptkb:South_San_Francisco,_California
|
| https://www.w3.org/2000/01/rdf-schema#label |
Federation Bio
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:investor |
gptkb:Alexandria_Venture_Investments
gptkb:Horizons_Ventures gptkb:Venrock Altitude Life Science Ventures |
| gptkbp:notableEmployee |
gptkb:Geoffrey_von_Maltzahn
Emily Drabant Conley John Eid |
| gptkbp:products |
engineered consortia of bacteria
|
| gptkbp:website |
https://www.federation.bio/
|
| gptkbp:bfsParent |
gptkb:Michael_Fischbach
|
| gptkbp:bfsLayer |
8
|